S. Suganya, P. S. Rajeswari and V. M. Karthi
Page: 73-78 | Received 19 Aug 2023, Published online: 03 Sep 2023
Full Text Reference XML File PDF File
To compare the efficacy, onset and duration of analgesia, as well as any potential side effects of hyperbaric racemic bupivacaine with hyperbaric levobupivacaine in spinal anaesthesia for elective lower abdominal surgeries. A prospective, randomized, double‐blinded study was conducted on patients undergoing elective lower abdominal surgeries. Participants were randomized into two groups: Those receiving hyperbaric racemic bupivacaine and those receiving hyperbaric levobupivacaine. Parameters such as onset of analgesia, duration of analgesia, hemodynamic stability and side effects were recorded and compared. There was a significant difference in the onset and duration of analgesia between the two groups. The hyperbaric levobupivacaine group demonstrated a quicker onset of analgesia and a longer duration of effective pain relief as compared to the hyperbaric racemic bupivacaine group. Hemodynamic parameters remained stable in both groups. The incidence of side effects was comparable, though specific details would be expanded upon in the full text. Hyperbaric levobupivacaine may offer advantages in terms of faster onset and prolonged duration of analgesia for spinal anesthesia in elective lower abdominal surgeries compared to hyperbaric racemic bupivacaine. Both agents demonstrated good safety profiles, suggesting that they are suitable options for this surgical context.
S. Suganya, P. S. Rajeswari and V. M. Karthi. Comparison of Hyperbaric Racemic Bupivacaine with Hyperbaric Levobupivacaine in Spinal Anaesthesia for Elective Lower Abdominal Surgeries: A Prospective Randomized Double
Blinded Study.
DOI: https://doi.org/10.36478/10.59218/makrjms.2023.8.73.78
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2023.8.73.78